• [stock-market-ticker symbols="AAPL;MSFT;GOOG;HPQ;^SPX;^DJI;LSE:BAG" stockExchange="NYSENasdaq" width"100%" palette="financial-light"]

    J&J Vaccine Trial Pause Slows Market Advance

    October 13, 2020
    No Comments
    J&J Vaccine Trial Pause Slows Market Advance
    Image by NIAID

    Johnson & Johnson has 'paused', not halted, development of a vaccine for the Chinese coronavirus due to an illness of one of the participants in the trials.

    “We’re letting safety protocol follow proper procedure here,” he said, adding that pauses in trials are “not uncommon," declared CEO Joseph Wolk on CNBC this morning.

    “What it should also do is reassure the public that every scientific, medical and ethical standard is being applied here,” Wolk added.

    “We must respect this participant’s privacy,” the company said in a statement late Monday. “We’re also learning more about this participant’s illness, and it’s important to have all the facts before we share additional information.”

    Airlines stocks fell as a result.

    Tech stocks rose again on positive news from Apple.

    American banks reported strong earnings.

    Consumer Price Index Core s.a. (Sep) printed at 296.26.

    Consumer Price Index (MoM) (Sep) printed at the consensus estimate of 0.2%.

    Consumer Price Index n.s.a. (MoM) (Sep) printed at 260.28 vs 260.348 estimate.

    Consumer Price Index ex Food & Energy (MoM) (Sep) printed at the estimate of 0.2%.

    Consumer Price Index (YoY) (Sep) printed at the estimate of 1.4%.

    Consumer Price Index ex Food & Energy (MoM) (Sep) printed at 1.7% vs 1.8% estimate.

    SHARE THIS ARTICLE

    Author

    CDM Staff

    The mission at Creative Destruction Media is to be the catalyst for the "process of industrial mutation that incessantly revolutionizes the economic structure from within, incessantly destroying the old one, incessantly creating a new one."
  • Subscribe
    Notify of
    guest

    0 Comments
    Inline Feedbacks
    View all comments

    FOLLOW US

  • Subscribe to our evening newsletter to stay informed during these challenging times!!

    ×